Krka, d. d.
KRK
株式のランク
#2136
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
株価
$315.87
時価総額
$9.56B
変化（1日）
0.90%
変化（1年）
28.29%
国
SI
取引 Krka, d. d. (KRK)
カテゴリー
Healthcare
Krka, d. d.（KRK）のP/E比率
October 2026 時点のP/E比率 TTM 19.17
Krka, d. d. の最新の財務報告および株価によると、現在の P/E (TTM) は 19.17 です。2023 年末時点での P/E は 10.10 でした。
Krka, d. d. の P/E 比率の履歴（2010 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 19.17 | 62.47% |
| 2024 | 11.80 | 16.87% |
| 2023 | 10.10 | 27.23% |
| 2022 | 7.94 | -34.24% |
| 2021 | 12.07 | 18.94% |
| 2020 | 10.15 | 8.51% |
| 2019 | 9.35 | -10.98% |
| 2018 | 10.51 | -11.02% |
| 2017 | 11.81 | -29.73% |
| 2016 | 16.80 | 23.10% |
| 2015 | 13.65 | 21.03% |
| 2014 | 11.28 | -1.67% |
| 2013 | 11.47 | 2.33% |
| 2012 | 11.21 | 15.69% |
| 2011 | 9.69 | -7.58% |
| 2010 | 10.48 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 34.96 | 82.35% |
IN
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。